RHINOMED LIMITED - Announcements

0.00%

4.0¢

Currently unlisted.

Rhinomed Limited is an Australia-based wearable nasal technology company. The Company is... Rhinomed Limited is an Australia-based wearable nasal technology company. The Company is engaged in the research, development and commercialization of consumer and medical devices. The Company’s products include Mute, Turbine, Rhinoswab Junior, and Rhinoswab. Mute technology is an easily inserted, comfortable and fully adjustable nasal stent or dilator. Turbine is designed to fit comfortably inside the nose and gently open each individual nostril to allow more airflow during sport, physical exertion, or focused breathing, such as yoga and meditation. Rhinoswab is a patented comfortable, self-administered nasal swab that provides high-yield sampling and fits existing pathology workflows.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RNO	Half Yearly Report and Accounts	PRICE SENSITIVE	02/03/20	709.16KB	Share
RNO	Change in substantial holding (WG)		12/02/20	79.28KB	Share
RNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/20	1.18MB	Share
RNO	Change of Director's Interest Notice - RD		28/01/20	202.87KB	Share
RNO	Change of Director's Interest Notice - MJ		28/01/20	203.46KB	Share
RNO	Change of Director's Interest Notice - EK		28/01/20	204.32KB	Share
RNO	Change of Director's Interest Notice - BS		28/01/20	203.26KB	Share
RNO	Appendix 3B		28/01/20	841.12KB	Share
RNO	Change in substantial holding (WG)		20/12/19	78.61KB	Share
RNO	2019 AGM Chairman's Address		29/11/19	102.82KB	Share
RNO	Results of Meeting		29/11/19	207.04KB	Share
RNO	Rhinomed AGM Presentation		29/11/19	1.96MB	Share
RNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/19	456.74KB	Share
RNO	Notice of Annual General Meeting/Proxy Form		25/10/19	797.79KB	Share
RNO	Appendix 4G and Corporate Governance Statement		25/10/19	338.52KB	Share
RNO	Annual Report to shareholders		25/10/19	1.49MB	Share
RNO	Becoming a substantial holder		14/10/19	188.24KB	Share
RNO	Ceasing to be a substantial holder from IFL		11/10/19	18.15KB	Share
RNO	Becoming a substantial holder from IFL		07/10/19	58.19KB	Share
RNO	Ceasing to be a substantial holder		02/10/19	183.06KB	Share
RNO	Audited Financial Report		30/09/19	989.81KB	Share
RNO	Appendix 3B, 708A Notice and LR 3.10.5A Information		27/09/19	373.28KB	Share
RNO	Capital Raising Investor Presentation	PRICE SENSITIVE	23/09/19	6.63MB	Share
RNO	Rhinomed Completes A$6.0 Million Capital Raising	PRICE SENSITIVE	23/09/19	180.37KB	Share
RNO	Trading Halt	PRICE SENSITIVE	19/09/19	478.45KB	Share
RNO	Rhinomed commence trading in the USA on the OTCQB market		12/09/19	77.69KB	Share
RNO	Change of address		04/09/19	130.29KB	Share
RNO	Preliminary Final Report	PRICE SENSITIVE	29/08/19	1.59MB	Share
RNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/19	1.23MB	Share
RNO	Rhinomed Bioshares Presentation		29/07/19	3.33MB	Share
RNO	Pronto Technology receives CE mark	PRICE SENSITIVE	15/07/19	552.15KB	Share
RNO	Mute the fastest growing product in category in US		11/07/19	227.38KB	Share
RNO	Change in substantial holding (WG)		02/07/19	181.13KB	Share
RNO	RNO SUPPORTS STUDY EXAMINING LINK BETWEEN SLEEP AND SUICIDE		28/06/19	130.57KB	Share
RNO	PRONTO RECHARGEABLE TECHNOLOGY REGISTERED WITH US FDA		17/05/19	672.18KB	Share
RNO	Change in substantial holding (WG)		06/05/19	175.5KB	Share
RNO	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/19	782.95KB	Share
RNO	RHINOMED LAUNCH REVOLUTIONARY TECHNOLOGY		15/04/19	367.12KB	Share
RNO	Change in substantial holding (DrJMcB)		28/03/19	194.82KB	Share
RNO	Change in substantial holding (WG)		01/03/19	373.89KB	Share
RNO	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/19	516.83KB	Share
RNO	Appendix 4C Quarterly and Business Update	PRICE SENSITIVE	29/01/19	1.55MB	Share
RNO	Change of Director's Interest Notice - RD		03/01/19	169.36KB	Share
RNO	Change of Director's Interest Notice - RD		24/12/18	470.47KB	Share
RNO	Change of Director's Interest Notice - MJ		24/12/18	416.5KB	Share
RNO	Change of Director's Interest Notice - EK		24/12/18	402.97KB	Share
RNO	Change of Director's Interest Notice - BS		24/12/18	413.52KB	Share
RNO	Share Purchase Plan Results		21/12/18	602.44KB	Share
RNO	Appendix 3B & 708A Notice		21/12/18	346.71KB	Share
RNO	Results of Meeting		14/12/18	231.43KB	Share
RNO	2018 AGM Chairman address & CEO presentation	PRICE SENSITIVE	14/12/18	5.88MB	Share
RNO	RNO Appoints CFO and Consolidates Australian Distribution		30/11/18	136.34KB	Share
RNO	Revised Indicative Timetable (Share Purchase Plan)		22/11/18	360.23KB	Share
RNO	Share Purchase Plan Offer Document	PRICE SENSITIVE	21/11/18	582.3KB	Share
RNO	Notice of Annual General Meeting/Proxy Form		14/11/18	1.42MB	Share
RNO	Appendix 3B, 708A Notice and LR 3.10.5A Information		09/11/18	1.43MB	Share
RNO	Change of Director's Interest Notice - RD		07/11/18	403.23KB	Share
RNO	Rhinomed Completes A$5.0 Million Capital Raise	PRICE SENSITIVE	02/11/18	410.06KB	Share
RNO	AGM to be held in December with ASIC approval		02/11/18	130.69KB	Share
RNO	Investor Presentation	PRICE SENSITIVE	31/10/18	12.5MB	Share
RNO	Appendix 4C Quarterly and Business Update	PRICE SENSITIVE	31/10/18	449.23KB	Share
RNO	Trading Halt	PRICE SENSITIVE	31/10/18	494.54KB	Share
RNO	Change in substantial holding (WG)		15/10/18	69.52KB	Share
RNO	US Medical Cannabis Licencing deal Investor Call		02/10/18	119.43KB	Share
RNO	RNO and Comumbia Care sign 12 yr deal for Medical Cannabis	PRICE SENSITIVE	01/10/18	176.22KB	Share
RNO	Appendix 4G		27/09/18	466.34KB	Share
RNO	Comporate Governance Statement		27/09/18	430.65KB	Share
RNO	Annual Report to shareholders		27/09/18	1.36MB	Share
RNO	September Update	PRICE SENSITIVE	19/09/18	125.13KB	Share
RNO	Change in substantial holding Dr JMcB		31/08/18	237.66KB	Share
RNO	Preliminary Final Report	PRICE SENSITIVE	31/08/18	408.71KB	Share
RNO	Investor Update		10/08/18	4.34MB	Share
RNO	Appendix 4C - Quarterly and Business Update	PRICE SENSITIVE	31/07/18	407.74KB	Share
RNO	Change in substantial holding Dr JMcB		02/07/18	198.21KB	Share
RNO	Change in substantial holding (WG)		26/06/18	447.54KB	Share
RNO	RNO and Columbia Care to develop cannabis based medicines	PRICE SENSITIVE	21/06/18	168.17KB	Share
RNO	Trading Halt	PRICE SENSITIVE	20/06/18	492.78KB	Share
RNO	Mute ranged into over 1100 new US Pharmacies	PRICE SENSITIVE	19/06/18	125.4KB	Share
RNO	Change in substantial holding (PS)		01/06/18	1.53MB	Share
RNO	Mute ranged into 3000 new US stores	PRICE SENSITIVE	28/05/18	137.7KB	Share
RNO	Trial of Mute in GNC ends	PRICE SENSITIVE	07/05/18	110.16KB	Share
RNO	Change in substantial holding (PS)		02/05/18	820.61KB	Share
RNO	Appendix 4C - quarterly and Business Update	PRICE SENSITIVE	19/04/18	388.23KB	Share
RNO	Becoming a substantial holder JMCB		29/03/18	165.78KB	Share
RNO	Change of Director's Interest Notice - RD		22/03/18	420.29KB	Share
RNO	Change of Director's Interest Notice - MJ		22/03/18	371.25KB	Share
RNO	Appendix 3B & Cleansing notice S708A		21/03/18	733.85KB	Share
RNO	Master Investor UK 2018 Presentation		19/03/18	4.93MB	Share
RNO	Becoming a substantial holder PS		06/03/18	81.73KB	Share
RNO	Becoming a substantial holder - PS		06/03/18	131.22KB	Share
RNO	Rhinomed to present at International Investor Conferences		05/03/18	110.51KB	Share
RNO	Change in Executive Remuneration		02/03/18	250.47KB	Share
RNO	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/18	827.39KB	Share
RNO	Appendix 4D - Half Year Financial Report - 31 December 2017	PRICE SENSITIVE	28/02/18	826.44KB	Share
RNO	Results of Meeting		22/02/18	744.84KB	Share
RNO	Expansion of US Distribution of Mute	PRICE SENSITIVE	05/02/18	119.66KB	Share
RNO	Appendix 4C - quarterly and Business Update	PRICE SENSITIVE	29/01/18	2.02MB	Share
RNO	Notice of General Meeting/Proxy Form		11/01/18	1.56MB	Share
RNO	Change in substantial holding RD		20/12/17	349.74KB	Share
RNO	Change of Director's Interest Notice RD		18/12/17	474.46KB	Share

RNO Half Yearly Report and Accounts
02/03/20	PRICE SENSITIVE	709.16KB	Share
RNO Change in substantial holding (WG)
12/02/20		79.28KB	Share
RNO Appendix 4C - quarterly
31/01/20	PRICE SENSITIVE	1.18MB	Share
RNO Change of Director's Interest Notice - RD
28/01/20		202.87KB	Share
RNO Change of Director's Interest Notice - MJ
28/01/20		203.46KB	Share
RNO Change of Director's Interest Notice - EK
28/01/20		204.32KB	Share
RNO Change of Director's Interest Notice - BS
28/01/20		203.26KB	Share
RNO Appendix 3B
28/01/20		841.12KB	Share
RNO Change in substantial holding (WG)
20/12/19		78.61KB	Share
RNO 2019 AGM Chairman's Address
29/11/19		102.82KB	Share
RNO Results of Meeting
29/11/19		207.04KB	Share
RNO Rhinomed AGM Presentation
29/11/19		1.96MB	Share
RNO Appendix 4C - quarterly
30/10/19	PRICE SENSITIVE	456.74KB	Share
RNO Notice of Annual General Meeting/Proxy Form
25/10/19		797.79KB	Share
RNO Appendix 4G and Corporate Governance Statement
25/10/19		338.52KB	Share
RNO Annual Report to shareholders
25/10/19		1.49MB	Share
RNO Becoming a substantial holder
14/10/19		188.24KB	Share
RNO Ceasing to be a substantial holder from IFL
11/10/19		18.15KB	Share
RNO Becoming a substantial holder from IFL
07/10/19		58.19KB	Share
RNO Ceasing to be a substantial holder
02/10/19		183.06KB	Share
RNO Audited Financial Report
30/09/19		989.81KB	Share
RNO Appendix 3B, 708A Notice and LR 3.10.5A Information
27/09/19		373.28KB	Share
RNO Capital Raising Investor Presentation
23/09/19	PRICE SENSITIVE	6.63MB	Share
RNO Rhinomed Completes A$6.0 Million Capital Raising
23/09/19	PRICE SENSITIVE	180.37KB	Share
RNO Trading Halt
19/09/19	PRICE SENSITIVE	478.45KB	Share
RNO Rhinomed commence trading in the USA on the OTCQB market
12/09/19		77.69KB	Share
RNO Change of address
04/09/19		130.29KB	Share
RNO Preliminary Final Report
29/08/19	PRICE SENSITIVE	1.59MB	Share
RNO Appendix 4C - quarterly
31/07/19	PRICE SENSITIVE	1.23MB	Share
RNO Rhinomed Bioshares Presentation
29/07/19		3.33MB	Share
RNO Pronto Technology receives CE mark
15/07/19	PRICE SENSITIVE	552.15KB	Share
RNO Mute the fastest growing product in category in US
11/07/19		227.38KB	Share
RNO Change in substantial holding (WG)
02/07/19		181.13KB	Share
RNO RNO SUPPORTS STUDY EXAMINING LINK BETWEEN SLEEP AND SUICIDE
28/06/19		130.57KB	Share
RNO PRONTO RECHARGEABLE TECHNOLOGY REGISTERED WITH US FDA
17/05/19		672.18KB	Share
RNO Change in substantial holding (WG)
06/05/19		175.5KB	Share
RNO Appendix 4C - quarterly
29/04/19	PRICE SENSITIVE	782.95KB	Share
RNO RHINOMED LAUNCH REVOLUTIONARY TECHNOLOGY
15/04/19		367.12KB	Share
RNO Change in substantial holding (DrJMcB)
28/03/19		194.82KB	Share
RNO Change in substantial holding (WG)
01/03/19		373.89KB	Share
RNO Half Yearly Report and Accounts
28/02/19	PRICE SENSITIVE	516.83KB	Share
RNO Appendix 4C Quarterly and Business Update
29/01/19	PRICE SENSITIVE	1.55MB	Share
RNO Change of Director's Interest Notice - RD
03/01/19		169.36KB	Share
RNO Change of Director's Interest Notice - RD
24/12/18		470.47KB	Share
RNO Change of Director's Interest Notice - MJ
24/12/18		416.5KB	Share
RNO Change of Director's Interest Notice - EK
24/12/18		402.97KB	Share
RNO Change of Director's Interest Notice - BS
24/12/18		413.52KB	Share
RNO Share Purchase Plan Results
21/12/18		602.44KB	Share
RNO Appendix 3B & 708A Notice
21/12/18		346.71KB	Share
RNO Results of Meeting
14/12/18		231.43KB	Share
RNO 2018 AGM Chairman address & CEO presentation
14/12/18	PRICE SENSITIVE	5.88MB	Share
RNO RNO Appoints CFO and Consolidates Australian Distribution
30/11/18		136.34KB	Share
RNO Revised Indicative Timetable (Share Purchase Plan)
22/11/18		360.23KB	Share
RNO Share Purchase Plan Offer Document
21/11/18	PRICE SENSITIVE	582.3KB	Share
RNO Notice of Annual General Meeting/Proxy Form
14/11/18		1.42MB	Share
RNO Appendix 3B, 708A Notice and LR 3.10.5A Information
09/11/18		1.43MB	Share
RNO Change of Director's Interest Notice - RD
07/11/18		403.23KB	Share
RNO Rhinomed Completes A$5.0 Million Capital Raise
02/11/18	PRICE SENSITIVE	410.06KB	Share
RNO AGM to be held in December with ASIC approval
02/11/18		130.69KB	Share
RNO Investor Presentation
31/10/18	PRICE SENSITIVE	12.5MB	Share
RNO Appendix 4C Quarterly and Business Update
31/10/18	PRICE SENSITIVE	449.23KB	Share
RNO Trading Halt
31/10/18	PRICE SENSITIVE	494.54KB	Share
RNO Change in substantial holding (WG)
15/10/18		69.52KB	Share
RNO US Medical Cannabis Licencing deal Investor Call
02/10/18		119.43KB	Share
RNO RNO and Comumbia Care sign 12 yr deal for Medical Cannabis
01/10/18	PRICE SENSITIVE	176.22KB	Share
RNO Appendix 4G
27/09/18		466.34KB	Share
RNO Comporate Governance Statement
27/09/18		430.65KB	Share
RNO Annual Report to shareholders
27/09/18		1.36MB	Share
RNO September Update
19/09/18	PRICE SENSITIVE	125.13KB	Share
RNO Change in substantial holding Dr JMcB
31/08/18		237.66KB	Share
RNO Preliminary Final Report
31/08/18	PRICE SENSITIVE	408.71KB	Share
RNO Investor Update
10/08/18		4.34MB	Share
RNO Appendix 4C - Quarterly and Business Update
31/07/18	PRICE SENSITIVE	407.74KB	Share
RNO Change in substantial holding Dr JMcB
02/07/18		198.21KB	Share
RNO Change in substantial holding (WG)
26/06/18		447.54KB	Share
RNO RNO and Columbia Care to develop cannabis based medicines
21/06/18	PRICE SENSITIVE	168.17KB	Share
RNO Trading Halt
20/06/18	PRICE SENSITIVE	492.78KB	Share
RNO Mute ranged into over 1100 new US Pharmacies
19/06/18	PRICE SENSITIVE	125.4KB	Share
RNO Change in substantial holding (PS)
01/06/18		1.53MB	Share
RNO Mute ranged into 3000 new US stores
28/05/18	PRICE SENSITIVE	137.7KB	Share
RNO Trial of Mute in GNC ends
07/05/18	PRICE SENSITIVE	110.16KB	Share
RNO Change in substantial holding (PS)
02/05/18		820.61KB	Share
RNO Appendix 4C - quarterly and Business Update
19/04/18	PRICE SENSITIVE	388.23KB	Share
RNO Becoming a substantial holder JMCB
29/03/18		165.78KB	Share
RNO Change of Director's Interest Notice - RD
22/03/18		420.29KB	Share
RNO Change of Director's Interest Notice - MJ
22/03/18		371.25KB	Share
RNO Appendix 3B & Cleansing notice S708A
21/03/18		733.85KB	Share
RNO Master Investor UK 2018 Presentation
19/03/18		4.93MB	Share
RNO Becoming a substantial holder PS
06/03/18		81.73KB	Share
RNO Becoming a substantial holder - PS
06/03/18		131.22KB	Share
RNO Rhinomed to present at International Investor Conferences
05/03/18		110.51KB	Share
RNO Change in Executive Remuneration
02/03/18		250.47KB	Share
RNO Half Yearly Report and Accounts
28/02/18	PRICE SENSITIVE	827.39KB	Share
RNO Appendix 4D - Half Year Financial Report - 31 December 2017
28/02/18	PRICE SENSITIVE	826.44KB	Share
RNO Results of Meeting
22/02/18		744.84KB	Share
RNO Expansion of US Distribution of Mute
05/02/18	PRICE SENSITIVE	119.66KB	Share
RNO Appendix 4C - quarterly and Business Update
29/01/18	PRICE SENSITIVE	2.02MB	Share
RNO Notice of General Meeting/Proxy Form
11/01/18		1.56MB	Share
RNO Change in substantial holding RD
20/12/17		349.74KB	Share
RNO Change of Director's Interest Notice RD
18/12/17		474.46KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

RHINOMED LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available